ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia
This study is currently recruiting participants.
Verified March 2013 by Altor Bioscience Corporation
Sponsor:
Altor Bioscience Corporation
Collaborator:
M.D. Anderson Cancer Center
Information provided by (Responsible Party):
Altor Bioscience Corporation
ClinicalTrials.gov Identifier:
NCT01478074
First received: November 17, 2011
Last updated: March 15, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | October 2013 (Final data collection date for primary outcome measure) |